디지털 창상 측정 기기 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the digital wound measurement devices market size is expected to grow from USD 318.91 million in 2025 to USD 335.36 million in 2026 and is forecast to reach USD 431.67 million by 2031 at 5.16% CAGR over 2026-2031.

This report is Segmented by Product (Contact Digital Measuring Devices, Non-Contact 2-D Camera-Based Devices, and More), Technology (2-D Digital Planimetry, and More), Wound Type (Chronic Wounds and Acute Wounds), End User (Hospitals, and More), Healthcare Setting (In-Patient, and More), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Digital Wound Measurement Devices Market Trends and Insights

Rising Prevalence of Chronic and Acute Wounds Worldwide

Diabetic foot ulcers now affect one quarter of the 537 million global diabetes population, while pressure ulcers and surgical site infections add to the escalating care burden. Chronic wounds consume 2-4% of national healthcare budgets, and a single diabetic foot ulcer episode can cost up to USD 27,721. Early use of digital measurement curbs healing time by as much as 50%, freeing clinical capacity and cutting resource waste. Cardiovascular disease, mobility disorders, and demographic aging broaden the wound population, reinforcing secular demand for precise tools. Consequently, clinicians and payers view the digital wound measurement devices market as an indispensable element in long-range chronic-disease management.

Technological Advancements in Imaging and Artificial Intelligence

MolecuLight fluorescence imaging detects bacterial load with 100% sensitivity, guiding targeted antibiotics that shorten recovery and lower expenses. Hyperspectral devices such as Kent Imaging SnapshotNIR quantify tissue oxygenation, showing wounds resolve 13.5 days after visible closure, thus offering earlier confidence for discharge decisions. Stereophotogrammetry now reaches sub-millimeter accuracy, and FDA-cleared smartphone apps like eKare inSight transform everyday cameras into clinical instruments. Continuous AI refinement creates a data flywheel: wider use generates richer datasets that further sharpen algorithms, enlarging the digital wound measurement devices market through compounded accuracy gains.

High Capital and Operational Costs of Advanced Devices

Up-front price tags of USD 15,000-50,000 per system and the need for software licenses, calibration, and 20-40 hours of staff training lift total cost of ownership above many clinic budgets. Rural hospitals must spread fixed charges across thin case volumes, impeding break-even targets. While smartphone apps lower entry thresholds, they may forfeit volumetric precision prized for complex wounds, forcing providers to weigh financial relief against clinical depth. Leasing schemes and outcome-based pricing emerge, yet capital hurdles still slow digital wound measurement devices market diffusion in resource-constrained settings.

Other drivers and restraints analyzed in the detailed report include:

1. Growing Emphasis on Value-Based Wound Care and Clinical Outcomes
2. Increasing Adoption of Digital Health and Telemedicine Platforms
3. Limited Reimbursement Coverage in Emerging Markets

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Non-Contact 2-D camera devices secured 56.78% of the digital wound measurement devices market size in 2025 because hospitals already use them inside established documentation routines. Yet software-only platforms claim the fastest 7.12% CAGR as AI upgrades push smartphone optics toward clinical parity. Early adopters report workflow gains because clinicians capture, annotate, and upload images within common mobile operating systems, eliminating cable transfers. Recurring license fees convert episodic capital sales into predictable revenue, rewarding data-science investments that uplift accuracy over time. Vendors such as Swift Medical raised USD 8 million in 2024 to deepen algorithm libraries that fuel this shift. Hardware makers respond by opening application-programming interfaces so their cameras feed these thriving ecosystems, confirming that future digital wound measurement devices market growth hinges on analytics more than optics.

Contact scanners keep niche relevance when tactile feedback informs debridement, and premium 3-D units capture volumetric change essential for deep ulcers. Yet their share may erode as mobile AI captures depth through structured-light processing at lower cost. Clinics hedge by pairing budget phones with cloud licenses, achieving entry-level precision now and upgrading optics later, thus preserving capital flexibility. As a result, software command grows while hardware commoditizes, cementing the digital wound measurement devices market evolution toward platform economics.

2-D planimetry dominated 48.05% of the digital wound measurement devices market share in 2025 thanks to its simple learning curve and quick capture times. However, 3-D stereophotogrammetry is scaling at a 7.38% CAGR because volume reduction correlates more tightly with healing than surface area alone. Surgeons treating cavity wounds prefer depth maps that confirm granulation across hidden pockets. Hyperspectral imaging further enriches decision-making by flagging perfusion deficits earlier than color change appears, enabling pre-emptive interventions that avert infection. Although fluorescence and thermal modalities remain niche, cross-modal devices will likely converge, giving clinicians a single toolset covering morphology and physiology.

Cost remains the main drag on 3-D adoption, yet leasing models and cloud-based processing ease budget shocks by swapping capital expense for service fees. Hospitals piloting stereo cameras show double-digit improvements in wound-closure prediction accuracy, a metric that feeds bundled-payment scorecards. Vendors thus spotlight outcome metrics rather than pixel counts when selling capability upgrades, and payers listen because validated precision drives down length of stay. Continuous gains in silicon efficiency will cut acquisition prices within the planning horizon, positioning 3-D stereophotogrammetry as the backbone of the digital wound measurement devices industry pipeline.

Complete Report Scope:

• By Product
  • Contact Digital Measuring Devices
  • Non-Contact 2-D Camera-Based Devices
  • 3-D Imaging / Scanner Devices
  • AI-Enabled Software-Only Solutions
• By Technology
  • 2-D Digital Planimetry
  • 3-D Stereophotogrammetry
  • Fluorescence / Hyperspectral Imaging
  • Thermal & Multimodal Imaging
• By Wound Type
  • Chronic Wounds
    • Pressure Ulcers
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Other Chronic Wounds
  • Acute Wounds
    • Surgical Wounds
    • Burns & Trauma
• By End User
  • Hospitals
  • Specialty Wound-Care Centers
  • Out-Patient Clinics
  • Home Healthcare Settings
• By Healthcare Setting
  • In-Patient
  • Out-Patient / Ambulatory
  • Home-Based
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America captured 39.78% of the digital wound measurement devices market in 2025, supported by Medicare billing codes 97597-97602 that offset acquisition and operating expense. U.S. hospitals face a USD 96 billion wound-care burden and deploy AI imaging to compress lengths of stay and avoid penalties tied to readmission metrics. Canadian health systems integrate imaging into province-wide electronic charts, while Mexico's expanding device imports fuel regional supplier pipelines. Regulatory clarity through FDA 510(k) and clinical trial infrastructure attract sustained venture funding, exemplified by MolecuLight's USD 27.5 million Series D in 2025. Such capital density perpetuates innovation cycles that reinforce North American dominance within the digital wound measurement devices market.

Asia-Pacific presents the fastest 6.31% CAGR, driven by state-sponsored telehealth strategies and smartphone saturation beyond 80% in large economies. China and India scale community-health initiatives that embed wound imaging inside primary-care apps, converting vast diabetic populations into data sources that refine AI. Japan and South Korea, coping with aging demographics, adopt advanced 3-D spectroscopy to limit long-term nursing stays. Regional procurement favors low-capex tools, so vendors localize pricing and cloud hosting to meet data-sovereignty rules. Collective momentum signals that APAC will steadily erode Western share through 2031, transforming the global digital wound measurement devices market.

Europe sustains measured growth under coordinated health technology assessments that demand robust outcome evidence before procurement. Germany and the United Kingdom lead uptake by linking imaging outputs to bundled payments for diabetic-foot pathways. France and Italy follow as EU digital-health funding windows open. GDPR compliance forces manufacturers to embed encryption and anonymization by design, raising entry barriers that favor vendors with mature data-governance frameworks. Consortia studying cross-border wound registries further boost data granularity, supporting pan-European best-practice guidelines and sustaining purchasing confidence in the digital wound measurement devices industry.

1. MolecuLight
2. ARANZ Medical Ltd.
3. Kent Imaging
4. eKare Inc.
5. WoundVision LLC
6. Tissue Analytics (Net Health)
7. Swift Medical Inc.
8. Perceptive Solutions (WoundZoom)
9. WoundMatrix Inc.
10. Parable Health
11. Healthy.io Ltd.
12. Spectral AI Inc.
13. KroniKare Pte Ltd.
14. Intellicure Inc.
15. Healogics Digital
16. Smiths Group
17. 3M Health Care
18. Stryker (Novadaq)
19. Medtronic
20. Digital Diagnostics

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope Of The Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence of Chronic and Acute Wounds Worldwide
  • 4.2.2 Increasing Adoption of Digital Health and Telemedicine Platforms
  • 4.2.3 Growing Emphasis on Value-Based Wound Care and Clinical Outcomes
  • 4.2.4 Technological Advancements in Imaging and Artificial Intelligence
  • 4.2.5 Expanding Geriatric Population and Surgical Procedures
  • 4.2.6 Favorable Regulatory and Reimbursement Support for Digital Solutions
• 4.3 Market Restraints
  • 4.3.1 High Capital and Operational Costs of Advanced Devices
  • 4.3.2 Limited Reimbursement Coverage in Emerging Markets
  • 4.3.3 Data Privacy and Cybersecurity Concerns In Cloud-Based Platforms
  • 4.3.4 Integration Challenges with Legacy Electronic Health Systems
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter?s Five Forces Analysis
  • 4.6.1 Threat Of New Entrants
  • 4.6.2 Bargaining Power Of Buyers
  • 4.6.3 Bargaining Power Of Suppliers
  • 4.6.4 Threat Of Substitute Products
  • 4.6.5 Intensity Of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Contact Digital Measuring Devices
  • 5.1.2 Non-Contact 2-D Camera-Based Devices
  • 5.1.3 3-D Imaging / Scanner Devices
  • 5.1.4 AI-Enabled Software-Only Solutions
• 5.2 By Technology
  • 5.2.1 2-D Digital Planimetry
  • 5.2.2 3-D Stereophotogrammetry
  • 5.2.3 Fluorescence / Hyperspectral Imaging
  • 5.2.4 Thermal & Multimodal Imaging
• 5.3 By Wound Type
  • 5.3.1 Chronic Wounds
    • 5.3.1.1 Pressure Ulcers
    • 5.3.1.2 Diabetic Foot Ulcers
    • 5.3.1.3 Venous Leg Ulcers
    • 5.3.1.4 Other Chronic Wounds
  • 5.3.2 Acute Wounds
    • 5.3.2.1 Surgical Wounds
    • 5.3.2.2 Burns & Trauma
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Specialty Wound-Care Centers
  • 5.4.3 Out-Patient Clinics
  • 5.4.4 Home Healthcare Settings
• 5.5 By Healthcare Setting
  • 5.5.1 In-Patient
  • 5.5.2 Out-Patient / Ambulatory
  • 5.5.3 Home-Based
• 5.6 Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
  • 6.3.1 MolecuLight Inc.
  • 6.3.2 ARANZ Medical Ltd.
  • 6.3.3 Kent Imaging Inc.
  • 6.3.4 eKare Inc.
  • 6.3.5 WoundVision LLC
  • 6.3.6 Tissue Analytics (Net Health)
  • 6.3.7 Swift Medical Inc.
  • 6.3.8 Perceptive Solutions (WoundZoom)
  • 6.3.9 WoundMatrix Inc.
  • 6.3.10 Parable Health
  • 6.3.11 Healthy.io Ltd.
  • 6.3.12 Spectral AI Inc.
  • 6.3.13 KroniKare Pte Ltd.
  • 6.3.14 Intellicure Inc.
  • 6.3.15 Healogics Digital
  • 6.3.16 Smith & Nephew PLC
  • 6.3.17 3M Health Care
  • 6.3.18 Stryker (Novadaq)
  • 6.3.19 Medtronic PLC
  • 6.3.20 Digital Diagnostics Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment